Clinical bottom line
Melatonin is a hormone that regulates sleep-wake cycles and is commonly used as a supplement for sleep disorders. Current evidence suggests that melatonin may be effective in improving sleep onset latency and overall sleep quality in certain populations, particularly those with delayed sleep phase disorder and insomnia. However, its efficacy can vary based on dosage, timing, and individual patient characteristics. Clinicians should consider these factors when recommending melatonin as part of a treatment plan for sleep disorders.
What the evidence shows
Recent systematic reviews and meta-analyses have evaluated the efficacy of melatonin in treating sleep disorders. A meta-analysis by Ferracioli-Oda et al. (2013) found that melatonin significantly reduced sleep onset latency and increased total sleep time in patients with primary sleep disorders (PMID: 23616697). Another systematic review by van Geijlswijk et al. (2010) highlighted melatonin's effectiveness in children with sleep onset insomnia and delayed sleep phase syndrome, noting improvements in sleep onset and duration (PMID: 20836780).
A more recent study by Liira et al. (2020) focused on adults with insomnia and found that melatonin improved sleep quality and reduced sleep onset latency, although the effect size was modest (PMID: 32023457). The study emphasized the importance of timing, suggesting that melatonin should be administered 1-2 hours before bedtime for optimal results.
Caveats and uncertainty
While melatonin is generally considered safe with few side effects, its efficacy can be inconsistent. The variability in study outcomes may be attributed to differences in study populations, melatonin formulations, dosages, and timing of administration. Additionally, the long-term safety of melatonin use remains unclear, particularly in children and adolescents.
The American Academy of Sleep Medicine (AASM) guidelines (2017) recommend against the routine use of melatonin for insomnia due to limited evidence of its effectiveness (PMID: 28574582). However, they acknowledge its potential benefit in circadian rhythm sleep-wake disorders, such as delayed sleep phase disorder.
How this may change practice
Clinicians should consider melatonin as a potential treatment option for patients with specific sleep disorders, particularly those related to circadian rhythm disturbances. When recommending melatonin, it is crucial to tailor the approach based on individual patient needs, including the timing of administration and dosage. Educating patients about the variability in response and setting realistic expectations is essential.
Further research is needed to establish standardized dosing regimens and to explore the long-term safety of melatonin use. Clinicians should remain informed about emerging evidence and guidelines to optimize the management of sleep disorders in primary care.